Patient presentation, intervention, and lesion characteristics
| No. of Patients with Data (%)a | Stroke inTerritory (%) (n = 20) | No Stroke in Territory (%) (n = 95) | |
|---|---|---|---|
| Days from last symptom to treatment | 115 | 32.8 ± 34.3 | 66.2 ± 124.2 |
| Treatment | |||
| Angioplasty | 38 (33) | 4 (11) | 34 (89) |
| BMS | 28 (24) | 5 (18) | 23 (82) |
| WS | 49 (43) | 11 (22) | 38 (78) |
| Presenting mRS at time of intervention | 115 (100) | 1.8 ± 1.3 | 1.4 ± 1.1 |
| % Stenosis before primary procedure | |||
| <70% | 7 (6) | 1 (14) | 6 (86) |
| ≥70% | 107 (94) | 19 (18) | 88 (82) |
| Qualifying event | |||
| TIA | 39 (34) | 8 (21) | 31 (79) |
| Minor stroke | 28 (25) | 7 (25) | 21 (75) |
| Major stroke | 46 (41) | 5 (11) | 41 (89) |
| Lesion location | |||
| ICA/VA | 46 (40) | 6 (13) | 40 (87) |
| MCA/BA | 68 (60) | 14 (21) | 54 (79) |
| Lesion morphology | |||
| Smooth | 80 (72) | 12 (15) | 68 (85) |
| Irregular | 31 (28) | 8 (26) | 23 (74) |
| Concentric | 58 (52) | 9 (16) | 49 (84) |
| Eccentric | 53 (48) | 11 (21) | 42 (79) |
| Ulceration | 17 (15) | 4 (24) | 13 (76) |
| No ulceration | 94 (85) | 16 (17) | 78 (83) |
| Lesion length | |||
| Short (<5 mm) | 44 (40) | 5 (11) | 39 (89) |
| Moderate (5–10 mm) | 17 (15) | 5 (29) | 12 (71) |
| Long (>10 mm) | 50 (45) | 10 (20) | 40 (80) |
| Activated clotting time at stent deployment | 85 (74) | 216.2 ± 32.5 | 217.0 ± 24.9 |
| Time from 1st visit until event (day) | 115 (100) | 25.9 ± 63.3 | 269.5 ± 133.2 |
a Data are not available for all patients.